Xtx Topco LTD Immuno Gen, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$3.67 - $4.92 $15,168 - $20,334	-4,133 Reduced 16.45%	20,994 $80,000
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $114,327 - $158,551	25,127 New	25,127 $124,000
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $40,764 - $74,540	-12,941 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $55,128 - $96,798	12,941 New	12,941 $62,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.